Supplemental Figure 2 from An Oral Formulation of YK-4-279: Preclinical Efficacy and Acquired Resistance Patterns in Ewing Sarcoma
Autor: | Joseph A. Ludwig, James E. O'Dorisio, Kirk S. Culotta, Dannette K. Doolittle, Adrianna S. Buford, Rebecca L. Maywald, Ramani A. Aiyer, Vandhana Ramamoorthy, Brian A. Menegaz, Salah-Eddine Lamhamedi-Cherradi |
---|---|
Rok vydání: | 2023 |
Popis: | Supplemental Figure 2. Nuclear, cytoplasmic and total RHA levels are identical between sensitive and YK-Resistant ES cell lines. |
Databáze: | OpenAIRE |
Externí odkaz: |